Treatment with DDX5-targeting 2F5 or anti-DDX5 siRNA could inhibit APL cell proliferation by downregulation of DDX5, inducing G0/G1 phase arrest. This evidence concerns the gene DDX5 and acute promyelocytic leukemia.